Critical Roles of METTL3 in Translation Regulation of Cancer

被引：9

作者：

Meng, Wangyang ^{[1
,2
]}

Xiao, Han ^{[1
]}

Mei, Peiyuan ^{[1
]}

Chen, Jiaping ^{[1
]}

Wang, Yangwei ^{[1
]}

Zhao, Rong ^{[1
]}

Liao, Yongde ^{[1
]}

机构：

[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Thorac Surg, Wuhan 430022, Peoples R China

[2] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Thorac Surg, Shanghai 200000, Peoples R China

来源：

BIOMOLECULES | 2023年 / 13卷 / 02期

基金：

中国国家自然科学基金;

关键词：

METTL3; m(6)A; translation regulation; post-transcriptional modification; eukaryotic initiation factor; RNA binding protein; cancer; MESSENGER-RNA; M(6)A METHYLATION; SUBUNIT; EXPRESSION; GENE; BREAST; EIF4E; TUMORIGENESIS; AMPLIFICATION; CLONING;

D O I：

10.3390/biom13020243

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Aberrant translation, a characteristic feature of cancer, is regulated by the complex and sophisticated RNA binding proteins (RBPs) in the canonical translation machinery. N6-methyladenosine (m(6)A) modifications are the most abundant internal modifications in mRNAs mediated by methyltransferase-like 3 (METTL3). METTL3 is commonly aberrantly expressed in different tumors and affects the mRNA translation of many oncogenes or dysregulated tumor suppressor genes in a variety of ways. In this review, we discuss the critical roles of METTL3 in translation regulation and how METTL3 and m(6)A reader proteins in collaboration with RBPs within the canonical translation machinery promote aberrant translation in tumorigenesis, providing an overview of recent efforts aiming to 'translate' these results to the clinic.

引用

页数：14

共 50 条

[31] METTL3 Plays Regulatory Roles in Acute Pneumonia during Staphylococcus aureus Infection
Wu, Menghui
Nie, Qihang
Zhang, Yanyan
Qin, Jiaoxia
Ye, Liumei
Zhao, Ruoyang
Dai, Menghong
Wu, Min
ACS INFECTIOUS DISEASES, 2025,
[32] METTL3 contributes to the pathogenesis of AKI
Carney, Ellen F.
NATURE REVIEWS NEPHROLOGY, 2022, 18 (06) : 345 - 345
[33] Analysis of METTL3 and METTL14 in hepatocellular carcinoma
Liu, Xiangxiang
Qin, Jian
Gao, Tianyi
Li, Chenmeng
Chen, Xiaoxiang
Zeng, Kaixuan
Xu, Mu
He, Bangshun
Pan, Bei
Xu, Xueni
Pan, Yuqin
Sun, Huiling
Xu, Tao
Wang, Shukui
AGING-US, 2020, 12 (21): : 21638 - 21659
[34] METTL3 restrains autoimmunity in β-cells
Krishnamurthy, Balasubramanian
Thomas, Helen E.
NATURE CELL BIOLOGY, 2024, 26 (03) : 321 - 322
[35] The role of the methyltransferase METTL3 in prostate cancer: a potential therapeutic target
Zhou, Xuming
Chai, Keqiang
Zhu, Hezhen
Luo, Cong
Zou, Xiaofeng
Zou, Junrong
Zhang, Guoxi
BMC CANCER, 2024, 24 (01)
[36] Clinical significance of METTL3 expression levels in gastric cancer patients
Okugawa, Yoshinaga
Toiyama, Yuji
Kitajima, Takahito
Shimura, Tadanobu
Yokoe, Takeshi
Hiro, Junichiro
Kusunoki, Masato
CANCER SCIENCE, 2021, 112 : 428 - 428
[37] The METTL3 RNA Methyltransferase Regulates Transcriptional Networks in Prostate Cancer
Haigh, Daisy B.
Woodcock, Corinne L.
Lothion-Roy, Jennifer
Harris, Anna E.
Metzler, Veronika M.
Persson, Jenny L.
Robinson, Brian D.
Khani, Francesca
Alsaleem, Mansour
Ntekim, Atara
Madhusudan, Srinivasan
Davis, Melissa B.
Laursen, Kristian B.
Gudas, Lorraine J.
Rutland, Catrin S.
Toss, Michael S.
Archer, Nathan
Bodi, Zsuzsanna
Rakha, Emad A.
Fray, Rupert G.
Jeyapalan, Jennie N.
Mongan, Nigel P.
CANCERS, 2022, 14 (20)
[38] The molecular mechanism of METTL3 promoting the malignant progression of lung cancer
Chao Ma
Rui-Jie Ma
Kang Hu
Qi-Ming Zheng
Ye-Peng Wang
Nan Zhang
Zhi-Gang Sun
Cancer Cell International, 22
[39] The role of the methyltransferase METTL3 in prostate cancer: a potential therapeutic target
Xuming Zhou
Keqiang Chai
Hezhen Zhu
Cong Luo
Xiaofeng Zou
Junrong Zou
Guoxi Zhang
BMC Cancer, 24
[40] Review of METTL3 in colorectal cancer: From mechanisms to the therapeutic potential
Zhang, Lexuan
Mao, Zhenwei
Yin, Kai
Wang, Shengjun
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 277

← 1 2 3 4 5 →